Inflammation following stroke

Journal of Clinical Neuroscience

Volumn 13, Issue 1, 2006, Pages 1-8

  Nilupul Perera, M ^a   Ma, Henry K ^a   Arakawa, Shuji ^a   Howells, David W ^a   Markus, Romesh ^a   Rowe, Christopher C ^a   Donnan, Geoffrey A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Animal stroke model; Haemorrhagic stroke; Inflammation; Ischaemic stroke; Neuroprotection

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; FIBRINOLYTIC AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPROTECTIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; ENCEPHALITIS; FIBRINOLYTIC THERAPY; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NEUTROPHIL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; STROKE; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 30344479448     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.07.005     Document Type: Short Survey

References (105)

1. Deaths by cause, sex and mortality stratum in WHO Regions, estimates for 2001. World Health Report. World Health Organization. 2002: Annex Table 2.
2. Global burden of coronary heart disease. In The Atlas of Heart Disease and Stroke. World Health Organization, 2004; 46-47.
3. J.C. Grotta, W.S. Burgin, and A. El-Mitwalli Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000 Arch Neurol 58 2001 2009 2013
4. R.L. Zhang, M. Chopp, and Y. Li Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat Neurology 44 1994 1747 1751
5. Y. Matsuo, H. Onodera, and Y. Shiga Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat Brain Res 656 1994 344 352
6. E.S. Connolly Jr., C.J. Winfree, and T.A. Springer Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke J Clin Invest 97 1996 209 216
7. H. Suzuki, T. Hayashi, and S.J. Tojo Anti-P-selectin antibody attenuates rat brain ischemic injury Neurosci Lett 265 1999 163 166
8. E.S. Connolly Jr., C.J. Winfree, and C.J. Prestigiacomo Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke Circ Res 81 1997 304 310
9. E. Morikawa, S.M. Zhang, Y. Seko, T. Toyoda, and T. Kirino Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin Stroke 27 1996 951 955
10. P.M. Hughes, P.R. Allegrini, M. Rudin, V.H. Perry, A.K. Mir, and C. Wiessner Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model J Cereb Blood Flow Metab 22 2002 308 317
11. Y. Chen, J.M. Hallenbeck, and C. Ruetzler Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells J Cereb Blood Flow Metab 23 2003 748 755
12. Y. Yamasaki, N. Matsuura, H. Shozuhara, H. Onodera, Y. Itoyama, and K. Kogure Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. [see comment] Stroke 26 1995 676 680
13. S.A. Loddick, and N.J. Rothwell Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat J Cereb Blood Flow Metab 16 1996 932 940
14. N.J. Mulcahy, J. Ross, N.J. Rothwell, and S.A. Loddick Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat Br J Pharmacol 140 2003 471 476
15. S.A. Loddick, A.V. Turnbull, and N.J. Rothwell Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat J Cereb Blood Flow Metab 18 1998 176 179
16. T. Matsumoto, K. Ikeda, and N. Mukaida Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8 Lab Invest 77 1997 119 125
17. P.A. Spera, J.A. Ellison, G.Z. Feuerstein, and F.C. Barone IL-10 reduces rat brain injury following focal stroke Neurosci Lett 251 1998 189 192
18. M. Grilli, I. Barbieri, and H. Basudev Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage Eur J Neurosci 12 2000 2265 2272
19. A.M. Romanic, R.F. White, A.J. Arleth, E.H. Ohlstein, and F.C. Barone Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size Stroke 29 1998 1020 1030
20. M. Asahi, K. Asahi, J.C. Jung, G.J. del Zoppo, M.E. Fini, and E.H. Lo Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94 J Cereb Blood Flow Metab 20 2000 1681 1689
21. L.A. Heinel, S. Rubin, R.H. Rosenwasser, U.S. Vasthare, and R.F. Tuma Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion Brain Res Bull 34 1994 137 141
22. Y. Matsuo, H. Onodera, and Y. Shiga Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion Stroke 25 1994 1469 1475
23. N. Jiang, M. Moyle, H.R. Soule, W.E. Rote, and M. Chopp Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats Ann Neurol 38 1995 935 942
24. K.B. Mackay, S.J. Bailey, P.D. King, S. Patel, T.C. Hamilton, and C.A. Campbell Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat Neurodegen 5 1996 319 323
25. H. Chen, M. Chopp, and R.L. Zhang Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat Ann Neurol 35 1994 458 463
26. S.G. Soriano, A. Coxon, and Y.F. Wang Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury Stroke 30 1999 134 139
27. K. Becker, D. Kindrick, J. Relton, J. Harlan, and R. Winn Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats Stroke 32 2001 206 211
28. X. Wang, L. Xu, H. Wang, Y. Zhan, E. Pure, and G.Z. Feuerstein CD44 deficiency in mice protects brain from cerebral ischemia injury J Neurochem 83 2002 1172 1179
29. Y. Yamasaki, Y. Matsuo, and J. Zagorski New therapeutic possibility of blocking cytokine-induced neutrophil chemoattractant on transient ischemic brain damage in rats Brain Res 759 1997 103 111
30. J.S. Beech, J. Reckless, D.E. Mosedale, D.J. Grainger, S.C. Williams, and D.K. Menon Neuroprotection in ischemia-reperfusion injury: an antiinflammatory approach using a novel broad-spectrum chemokine inhibitor J Cereb Blood Flow Metab 21 2001 683 689
31. D.A. Dawson, D. Martin, and J.M. Hallenbeck Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat Neurosci Lett 218 1996 41 44
32. G.Y. Yang, C. Gong, Z. Qin, W. Ye, Y. Mao, and A.L. Bertz Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain NeuroReport 9 1998 2131 2134
33. S. Yamagami, M. Tamura, and M. Hayashi Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats J Leukocyte Biol 65 1999 744 749
34. S.J. Liu, S.W. Zhou, and C.S. Xue Effect of tetrandrine on neutrophilic recruitment response to brain ischemia/reperfusion Acta Pharmacol Sinica 22 2001 971 975
35. X. Wang, T.L. Yue, R.F. White, F.C. Barone, and G.Z. Feuerstein Transforming growth factor-beta 1 exhibits delayed gene expression following focal cerebral ischemia Brain Res Bull 36 1995 607 609
36. T. Liu, R.K. Clark, and P.C. McDonnell Tumor necrosis factor-alpha expression in ischemic neurons Stroke 25 1994 1481 1488
37. X. Wang, A.L. Siren, Y. Liu, T.L. Yue, F.C. Barone, and G.Z. Feuerstein Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex Brain Res Mol Brain Res 26 1994 61 68
38. G.Y. Yang, G.P. Schielke, and C. Gong Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice J Cereb Blood Flow Metab 19 1999 1109 1117
39. H. Ohtaki, H. Funahashi, and K. Dohi Suppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin-1 Neurosci Res 45 2003 313 324
40. D.A. Skifter, P.R. Allegrini, C. Wiessner, and A.K. Mir Similar time-course of interleukin-1 beta production and extracellular-signal-regulated kinase (ERK) activation in permanent focal brain ischemic injury Metab Brain Dis 17 2002 131 138
41. X. Wang, F.C. Barone, N.V. Aiyar, and G.Z. Feuerstein Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats Stroke 28 1997 155 161
42. H. Ge, Y. Wen, G. Yang, and A.L. Betz Increased expression of intercellular adhesion molecule-1 in mouse focal cerebral ischemia model Chinese Med J 113 2000 75 79
43. X. Che, W. Ye, L. Panga, D.C. Wu, and G.Y. Yang Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice Brain Res 902 2001 171 177
44. J.J. Legos, R.G. Whitmore, J.A. Erhardt, A.A. Parsons, R.F. Tuma, and F.C. Barone Quantitative changes in interleukin proteins following focal stroke in the rat Neurosci Lett 282 2000 189 192
45. W.M. Clark, L.G. Rinker, N.S. Lessov, K. Hazel, and F. Eckenstein Time course of IL-6 expression in experimental CNS ischemia Neurol Res 21 1999 287 292
46. R. Gregersen, K. Lambertsen, and B. Finsen Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice J Cereb Blood Flow Metab 20 2000 53 65
47. M. Schroeter, P. Kury, and S. Jander Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice Brain Res Mol Brain Res 117 2003 1 7
48. S. Jander, M. Schroeter, and G. Stoll Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response J Cereb Blood Flow Metab 22 2002 62 70
49. X. Wang, T.L. Yue, F.C. Barone, R.F. White, R.C. Gagnon, and G.Z. Feuerstein Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia Mol Chem Neuropathol 23 1994 103 114
50. R. Bertorelli, M. Adami, E. Di Santo, and P. Ghezzi MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain Neurosci Lett 246 1998 41 44
51. M. Buttini, A. Sauter, and H.W. Boddeke Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat Brain Res Mol Brain Res 23 1994 126 134
52. X. Wang, T.L. Yue, F.C. Barone, and G.Z. Feuerstein Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex Stroke 26 1995 661 665
53. S. Nogawa, F. Zhang, M.E. Ross, and C. Iadecola Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage J Neurosci 17 1997 2746 2755
54. M. Nagayama, K. Niwa, T. Nagayama, M.E. Ross, and C. Iadecola The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene J Cereb Blood Flow Metab 19 1999 1213 1219
55. W.B. Veldhuis, J.W. Derksen, and S. Floris Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat J Cereb Blood Flow Metab 23 2003 1029 1039
56. A.J. Williams, R. Berti, J.R. Dave, P.J. Elliot, J. Adams, and F.C. Tortella Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519 Stroke 35 2004 1186 1191
57. Y.F. Wang, S.E. Tsirka, S. Strickland, P.E. Stieg, S.G. Soriano, and S.A. Lipton Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice [see comment] Nature Med 4 1998 228 231
58. B.E. Figueroa, R.F. Keep, A.L. Betz, and J.T. Hoff Plasminogen activators potentiate thrombin-induced brain injury Stroke 29 1998 1202 1207
59. M.P. Flavin, G. Zhao, and L.T. Ho Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro Glia 29 2000 347 354
60. J. Kaur, Z. Zhao, G.M. Klein, E.H. Lo, and A.M. Buchan The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 24 2004 945 963
61. R.L. Zhang, Z.G. Zhang, and M. Chopp Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat Neurology 52 1999 273 279
62. L. Zhang, Z.G. Zhang, R.L. Zhang, M. Lu, M. Krams, and M. Chopp Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke Stroke 34 2003 1790 1795
63. T. Kano, Y. Katayama, E. Tejima, and E.H. Lo Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of Stroke Brain Res 854 2000 245 248
64. P.A. Lapchak, D.F. Chapman, and J.A. Zivin Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic Stroke 31 2000 3034 3040
65. T. Sumii, and E.H. Lo Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats Stroke 33 2002 831 836
66. R.M. Dijkhuizen, M. Asahi, O. Wu, B.R. Rosen, and E.H. Lo Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model Stroke 33 2002 2100 2104
67. L. Zhang, Z.G. Zhang, and R.L. Zhang Postischemic (6-hour) treatment with recombinant human tissue plasminogen activator and proteosome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia Stroke 32 2001 2926 2931
68. M. Maeda, Y. Furuichi, and N. Ueyama A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window J Cereb Blood Flow Metab 22 2002 1205 1211
69. M.P. Bowes, R. Rothlein, S.C. Fagan, and J.A. Zivin Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy Neurology 45 1995 815 819
70. L. Zhang, Z.G. Zhang, and R. Zhang Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke [see comment] Circulation 107 2003 2837 2843
71. C. Gong, J.T. Hoff, and R.F. Keep Acute inflammatory reaction following experimental intracerebral hemorrhage in rat Brain Res 871 2000 57 65
72. M. Xue, and M.R. Del Bigio Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death Neurosci Lett 283 2000 230 232
73. K. Chu, S.W. Jeong, and K.H. Jung Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death J Cereb Blood Flow Metab 24 2004 926 933
74. J. Peeling, H.J. Yan, D. Corbett, M. Xue, and M.R. Del Bigio Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat Exp Neurol 167 2001 341 347
75. M.R. Del Bigio, H.J. Yan, T.M. Campbell, and J. Peeling Effect of fucoidan treatment on collagenase-induced intracerebral hemorrhage in rats Neurol Res 21 1999 415 419
76. K.H. Jung, K. Chu, and S.W. Jeong HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage Stroke 35 2004 1744 1749
77. R.E. Clatterbuck, P. Gailloud, and L. Ogata Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates J Neurosurg 99 2003 376 382
78. M. Bavbek, R. Polin, A.L. Kwan, A.S. Arthur, N.F. Kassell, and K.S. Lee Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits Stroke 29 1998 1930 1935
79. M. Satoh, I. Date, and M. Nakajima Inhibition of poly (ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits Stroke 32 2001 225 231
80. T. Sasaki, H. Kasuya, and H. Onda Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage Stroke 35 2004 1466 1470
81. J. Zaremba, and J. Losy The levels of TNF-alpha in cerebrospinal fluid and serum do not correlate with the counts of the white blood cells in acute phase of ischaemic stroke Folia Morphol (Warsz) 60 2001 91 97
82. E.D. Pedersen, U. Waje-Andreassen, C.A. Vedeler, G. Aamodt, and T.E. Mollnes Systemic complement activation following human acute ischaemic stroke Clin Exp Immunol 137 2004 117 122
83. N. Vila, X. Filella, R. Deulofeu, C. Ascaso, R. Abellana, and A. Chamorro Cytokine-induced inflammation and long-term stroke functional outcome J Neurol Sci 162 1999 185 188
84. H.C. Emsley, C.J. Smith, and C.M. Gavin An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis J Neuroimmunol 139 2003 93 101
85. R. Chuaqui, and J. Tapia Histologic assessment of the age of recent brain infarcts in man J Neuropathol Exp Neurol 52 1993 481 489
86. H. Mena, D. Cadavid, and E. Rushing Human cerebral infarct: a proposed histopathologic classification based on 137 cases Acta Neuropathol (Berl) 108 2004 524 530
87. E. Tarkowski, L. Rosengren, and C. Blomstrand Intrathecal release of pro- and anti-inflammatory cytokines during stroke Clin Exp Immunol 110 1997 492 499
88. E. Tarkowski, L. Rosengren, and C. Blomstrand Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke Stroke 26 1995 1393 1398
89. D. Intiso, M.M. Zarrelli, and G. Lagioia Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients Neurol Sci 24 2004 390 396
90. J. Zaremba, and J. Losy Interleukin-18 in acute ischaemic stroke patients Neurol Sci 24 2003 117 124
91. F. Perini, M. Morra, M. Alecci, E. Galloni, M. Marchi, and V. Toso Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients [see comment] Neurol Sci 22 2001 289 296
92. K. Fassbender, S. Rossol, and T. Kammer Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease J Neurol Sci 122 1994 135 139
93. C. Ferrarese, P. Mascarucci, and C. Zoia Increased cytokine release from peripheral blood cells after acute stroke J Cereb Blood Flow Metab 19 1999 1004 1009
94. A. Bitsch, W. Klene, L. Murtada, H. Prange, and P. Rieckmann A longitudinal prospective study of soluble adhesion molecules in acute stroke Stroke 29 1998 2129 2135
95. N. Kostulas, S.H. Pelidou, P. Kivisakk, V. Kostulas, and H. Link Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study Stroke 30 1999 2174 2179
96. C.J. Smith, H.C. Emsley, and C.M. Gavin Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome BMC Neurology 4 2004 15
97. N. Vila, J. Castillo, A. Davalos, and A. Chamorro Proinflammatory cytokines and early neurological worsening in ischemic stroke [see comment] Stroke 31 2000 2325 2329
98. K.W. Muir, C.J. Weir, W. Alwan, I.B. Squire, and K.R. Lees C-reactive protein and outcome after ischemic stroke Stroke 30 1999 981 985
99. C.J. Price, D.K. Menon, and A.M. Peters Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study Stroke 35 2003 1659 1664
100. A. Saleh, M. Schroeter, C. Jonkmanns, H.P. Hartung, U. Modder, and S. Jander In vivo MRI of brain inflammation in human ischaemic stroke Brain 127 2004 1670 1677
101. A. Gerhard, B. Neumaier, and E. Elitok In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke NeuroReport 11 2000 2957 2960
102. S. Pappata, M. Levasseur, and R.N. Gunn Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195 Neurology 55 2000 1052 1054
103. Enlimomab Acute Stroke Trial I Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial Neurology 57 2001 1428 1434
104. K.R. Lees, H.C. Diener, K. Asplund, M. Krams, and S.I. Uk UK-279,276, a neutrophil inhibitory glycoprotein, in acute stroke: tolerability and pharmacokinetics Stroke 34 2003 1704 1709
105. M. Krams, K.R. Lees, and W. Hacke Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke [see comment] Stroke 34 2003 2543 2548